DCN and neoplasm: Certain proteoglycans, such as syndecan-1 and glypican-1, promote tumor growth and dissemination by enhancing growth factor signaling and cell migration, whereas others, including decorin and lumican, inhibit tumor progression by modulating immune responses and collagen fibrillogenesis.